Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study

OBJECTIVES: To compare rates of switchbacks to branded drug products for patients switched from branded to authorized generic drug products, which have the same active ingredients, appearance, and excipients as the branded product, with patients switched from branded to generic drug products, which...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ
Hlavní autoři: Desai, Rishi J, Sarpatwari, Ameet, Dejene, Sara, Khan, Nazleen F, Lii, Joyce, Rogers, James R, Dutcher, Sarah K, Raofi, Saeid, Bohn, Justin, Connolly, John, Fischer, Michael A, Kesselheim, Aaron S, Gagne, Joshua J
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group Ltd. 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881140/
https://ncbi.nlm.nih.gov/pubmed/29615391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.k1180
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky